• The Netherlands Cancer Institute
  • |
  • Antoni van Leeuwenhoek Ziekenhuis
  • home|
  • contact|
  • staff members|
  • sitemap|
  • vacancies|
  • search
search
  • Home >
  • Search

Advanced search








Search again
  • About the Netherlands Cancer Institute
    • About the Netherlands Cancer Institute
    • Welcome by the scientific director
    • The history of The Netherlands Cancer Institute
      • The Netherlands Cancer Institute
      • Antoni van Leeuwenhoek
    • Leadership
      • Patron
      • Board of Governors
      • Board of Directors
      • Management Team
      • Scientific Advisory Board
      • Research Council
      • Faculty Council
      • Administrative departments
    • Scientific report
  • Faculty and Research
    • Faculty
    • Divisions
      • Immunology
      • Gene Regulation
      • Cell Biology I
      • Cel Biology II
      • Molecular Carcinogenesis
      • Biochemistry
      • Molecular Biology
      • Molecular Genetics
      • Experimental Therapy
      • Psychosocial Research and Epidemiology
      • Radiotherapy
      • Medical Oncology
      • Surgical Oncology
      • Diagnostic Oncology
    • Clinical Research
    • NKI comprehensive cancer center
    • Centre for Biomedical Genetics
    • Cancer Genomics Center
    • International BRCA1 -2 Carrier Cohort Study (IBCCS)
    • Support facilities
      • Library
    • Amsterdam Breast Cancer Study (ABCS)
  • News and Communication
    • News
      • Two million euros to fight lung cancer
      • Vici grant for chromosome organisation
      • Mirjam Epping receives Rubicon
      • Ton Schumacher receives grant
      • How inflammatory proteins can protect against cancer
      • Discovery of several hundreds of potential cancer genes
      • Thesis Anja Duursma
      • Thesis Anna Keller
      • Vidi-grants for Elisabetta Citterio and Karin de Visser
      • Genetic profiling breast cancer
      • Appointment Professor Daniel Peeper
      • Appointment Professor John Haanen
      • European Comprehensive Cancer Center Alliance (ECCCA)
      • Thesis Nuno Rocha
      • Thesis defence Annelies Jorritsma
      • Appointment Professor Reuven Agami
      • Biomarker associated with poor outcome in aggressive childhood cancer
      • Collaboration between NKI-AVL AstraZeneca and Agendia wins Best Partnership Alliance Award
      • coorperating oncogenes
      • Impact blood-brain barrier in brain tumor chemotherapy
      • NKI withdraws two scientific publications
    • Press releases
      • Vidi-grants for Elisabetta Citterio and Karin de Visser
      • Discovery of several hundreds of potential cancer genes
      • A novel family of antibiotics
      • EMBO welcomes fifty leading scientists
      • Top cancer grant to NKI-AvL researcher Daniel Peeper
      • p15 critical tumour suppressor in absence of p16
      • In biology polarization is a good thing
      • How inflammatory proteins can protect against cancer
      • EMBO honours Daniel Peeper and Bas van Steensel as leading life scientists
      • European Comprehensive Cancer Centre Alliance (ECCCA)
      • New tumor inhibitor for treatment of hereditary breast cancer shows promising results
    • Publications
      • Scientific brochure
      • General brochure
      • Scientific report
    • Contact us
    • Image gallery
    • Archive news
      • Archive news 2007
      • Archive news 2006
      • Archive news 2008
    • Archive Press releases
      • 2007
      • 2006
  • Seminars and Events
    • Scientific seminars
    • Scientific meetings
    • Events
      • Advances in cancer research from mice to men
      • Radiation exposure from computed tomography scans and cancer risk
      • Workshop on Innovative Mouse Models
    • Calendar
  • Career & Training
    • Faculty
    • Postdoctoral fellows
    • Graduate students
    • Masters students
    • Vacancies
      • Faculty
      • Postdoctoral Fellows
      • Graduate Students
      • Technicians and Research support personnel
      • Other
    • senior technology transfer manager
  • Technology Transfer
    • Information for businesses
      • Key technology areas
      • Licensing opportunities
      • Reagents
      • Spin outs
    • Information for patients - Informatie voor patiënten
    • The team
    • Contact